AbbVie to Host First-Quarter 2026 Earnings Call

Pharmaceutical company to report financial results on April 29, 2026.

Mar. 31, 2026 at 12:05pm

An extreme close-up of highly detailed, metallic pharmaceutical manufacturing equipment, conveying the technical and industrial nature of the industry without using any text or identifiable elements.AbbVie's quarterly earnings report offers a glimpse into the inner workings of the pharmaceutical industry's complex machinery.North Chicago Today

AbbVie, a major pharmaceutical company, will announce its first-quarter 2026 financial results on Wednesday, April 29, 2026, before the market opens. The company will host a live webcast of the earnings conference call at 8 a.m. Central time, which will be accessible through AbbVie's Investor Relations website.

Why it matters

As a leading pharmaceutical company, AbbVie's quarterly earnings report is closely watched by investors and analysts to gauge the company's financial health and performance across its key therapeutic areas, including immunology, neuroscience, oncology, and aesthetics.

The details

AbbVie will report its Q1 2026 financial results and host a live webcast of the earnings conference call on April 29, 2026. The webcast will be available on the company's Investor Relations website.

  • AbbVie will announce its Q1 2026 financial results on Wednesday, April 29, 2026, before the market opens.
  • The live webcast of the earnings conference call will be held at 8 a.m. Central time on April 29, 2026.

The players

AbbVie

A major pharmaceutical company that discovers and delivers innovative medicines and solutions across several key therapeutic areas, including immunology, neuroscience, oncology, and aesthetics.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be closely watching AbbVie's Q1 2026 earnings report and conference call for insights into the company's financial performance and outlook.

The takeaway

As a leading pharmaceutical company, AbbVie's quarterly earnings report is an important indicator of the overall health and direction of the industry, providing valuable information for investors and the broader market.